Physician Search

Biomarker Analysis of Breast Cancer Patients Receiving Immunotherapy

Breast

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of CAEL-101 and Plasma Cell Dyscrasia Treatment Versus Placebo and Plasma Cell Dyscrasia Treatment in Plasma Cell Dyscrasia Treatment-Nave Patients with Mayo Stage IIIb AL Amyloidosis.

Hematologic

Patient and Health Care Provider Perspectives of Naloxone

Miscellaneous

A Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations

Multiple Cancer Types

A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants with RCC (U03): Substudy 03B

A Prospective Observational Cohort Study to Assess miRNA 371 for Outcome Prediction in Patients with Newly Diagnosed Germ Cell Tumors

Urologic

ON-TRK: PrOspective Non-Interventional Study in Patients with Locally Advanced or Metastatic TRK Fusion Cancer Treated with Larotrectinib

Multiple Cancer Types

A Phase 3, Randomized, Multi-Center, Open-Label Study of Trastuzumab Deruxtecan (T-DXd) versus Investigator s Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Breast Cancer Patients Whose Disease Has Progressed on Endocrine Therapy in the Metastatic Setting (DESTINY-Breast06)

Breast

Pattern of Changes in Immune Profile in the Setting of Chimeric Antigen Receptor T-Cell Therapy

Miscellaneous

Sexual Function in Women After Radical Cystectomy

Bladder